Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded Peptide
Authors:
- Susan J. RoskopfSRSusan J. Roskopf
- Garry P. NolanGNGarry P. Nolan
- Michael I. NishimuraMNMichael I. Nishimura
- 1 February 2001
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 98 (2) , 220-228
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Quantitative and Qualitative Signals Determine T-Cell Cycle Entry and ProgressionCellular Immunology, 1999
- β2-Integrin, LFA-1, and TCR/CD3 Synergistically Induce Tyrosine Phosphorylation of Focal Adhesion Kinase (pp125FAK) in PHA-Activated T CellsCellular Immunology, 1999
- Feasibility of Cellular Adoptive Immunotherapy for Epstein-Barr Virus-Associated Lymphomas Using Haploidentical DonorsJournal of Hematotherapy, 1998
- Gene Therapy in the United States: A Five-Year Status ReportHuman Gene Therapy, 1996
- Transporter (TAP)‐independent processing of a multiple membrane‐spanning protein, the Epstein‐Barr virus latent membrane protein 2European Journal of Immunology, 1996
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).Journal of Experimental Medicine, 1990
- A 45‐kDa human T‐cell membrane glycoprotein functions in the regulation of cell proliferative responsesEuropean Journal of Biochemistry, 1984
- Epstein–Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigenNature, 1982